Skip to content
505050BXTBXTBXT

Drawing based on the label description. No photo yet.

“Tablets are white with blue flecks and imprinted with 50 on one side and BXT on the other”

BXT 50 pill

Pill with imprint BXT 50 is white, round, 11 mm and has been identified as Cyclophosphamide 50 mg. It is used for multiple sclerosis, myasthenia gravis and breast cancer. It is supplied by Baxter Healthcare Company.

Cyclophosphamide 50 mg

Imprint
BXT 50
Strength
50 mg
Used for
Multiple sclerosis, myasthenia gravis and breast cancer
Color
White
Shape
Round
Size
11 mm
Score
No score line
Form
Tablet
Manufacturer
Baxter Healthcare Company
Drug class
Cancer or immune medicine
NDC
10019-984, 10019-984-09, 10019-984-01

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Cyclophosphamide pills and guides

What is Cyclophosphamide used for?

Cyclophosphamide is used for multiple sclerosis, myasthenia gravis, breast cancer and multiple myeloma.

Medicine type
Cancer or immune medicine
Official uses from the US prescribing label

Malignant Diseases

Cyclophosphamide capsules are indicated for the treatment of: • malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin’s disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt’s lymphoma • multiple myeloma • leukemias: chronic lymphocytic leukemia, chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis), acute myelogenous and monocytic leukemia, acute lymphoblastic (stem-cell) leukemia (cyclophosphamide given during remission is effective in prolonging its duration) • mycosis fungoides (advanced disease) • neuroblastoma (disseminated disease) • adenocarcinoma of the ovary • retinoblastoma • carcinoma of the breast

Cyclophosphamide capsules, although effective alone in susceptible malignancies, is more frequently used concurrently or sequentially with other antineoplastic drugs.

Minimal Change Nephrotic Syndrome in Pediatric Patients

Cyclophosphamide capsules are indicated for the treatment of biopsy proven minimal change nephrotic syndrome in pediatric patients who failed to adequately respond to or are unable to tolerate adrenocorticosteroid therapy.

Limitations of Use:

The safety and effectiveness of cyclophosphamide capsules for the treatment of nephrotic syndrome in adults or other renal disease has not been established.

From the FDA-approved label on DailyMed (published Sep 29, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 50 and the other side shows BXT.
  • It is white, round, 11 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Cyclophosphamide

Also distributed by

Baxter Healthcare Corporation

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Cyclophosphamide pills